...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Great Presetation today
3
Oct 17, 2017 03:14PM
3
bfw
Oct 17, 2017 07:16PM
4
Oct 18, 2017 06:20AM
5
Oct 18, 2017 02:17PM
4
Oct 18, 2017 04:27PM
4
Oct 18, 2017 06:11PM
3
Oct 19, 2017 09:40AM

As far as the go forward is concerned, yes we are saying the same thing. Yes someone could invest in a 100% owned subsidiary, the only thing that changes is the subsidiary is no longer 100% owned.  That being said dilution then only occurs at the subsidiary level.  Don had said that this was one of the main reasons for the reorg, to prevent dilution of the Royalty Preferreds. Thus far that has not occurred and if this latest investment is in ZCC, as per slide 3, then the dilution in the RPs  continues. Management really seems to have a very hard time with delivering on the simple concept of “say what you mean and mean what you say”. 

1
Oct 19, 2017 02:51PM
4
Oct 19, 2017 07:22PM
2
Oct 20, 2017 02:04AM
3
Oct 20, 2017 10:35AM
2
Oct 21, 2017 11:36AM
3
Oct 23, 2017 12:27PM
3
Oct 24, 2017 02:27AM
4
Oct 24, 2017 01:39PM
Share
New Message
Please login to post a reply